Young Physicians and Money

Young Physicians and Money

Online Exclusive

Dr. Setu Mazumdar and Dr. Greg Henry discuss paying off student debt and the significance of savings

For Better PPE, Go Back to the Drawing Board

For Better PPE, Go Back to the Drawing Board

Tech Doc

An EP teams up with a fashion designer to imagine the next phase in personal protective equipment

A Day in the Life of a TeleDoc

A Day in the Life of a TeleDoc

Telemedicine

Haywood Hall pursues his passion for global health (in Mexico) while treating US patients on his phone (for US dollars)

To Tweet Or Not To Tweet

To Tweet Or Not To Tweet

Oh Henry

Let us not sacrifice human contact and self exploration on the altar of social media

Finding the Foley

Finding the Foley

Soundings

Use ultrasound to diagnose – and quickly remedy – this acute urinary retention

Building a Smarter Staffing Model

Building a Smarter Staffing Model

Manpower

Better analytics can help your emergency department staff for tomorrow’s peaks and valleys

I Resolve...To Toast the Team

I Resolve...To Toast the Team

Essay

The fabric of our profession is sometimes lost in daily routines — but there’s nothing ordinary about it

Rx Pad: All About Oseltamivir

Rx Pad: All About Oseltamivir

2015 Flu Review

The decision to treat with a neuraminidase inhibitor requires a risk-benefit analysis

Pediatric Flu: One Size Does Not Fit All

Pediatric Flu: One Size Does Not Fit All

2015 Flu Review

Controversy continues over oseltamivir, but don’t throw the baby out with the bathwater

The Case Against Tamiflu

The Case Against Tamiflu

2015 Flu Review

What to consider if flu-like symptoms have you reaching reflexively for oseltamivir

Keeping Up with Influenza

Keeping Up with Influenza

2015 Flu Review

As you’re bombarded this winter with sick flu patients and sensational flu headlines, it helps to go back to basics

Step It Up: 5 Habits of Successful EPs

Step It Up: 5 Habits of Successful EPs

Director's Corner

How do you define success in emergency medicine, and how to move in that direction

Frontpage Slideshow | Copyright © 2006-2014 JoomlaWorks Ltd.
Print
E-mail
Reprint

Schizophrenia, the most common psychotic disorder, affects 1 percent of the general population.  The symptoms begin in late adolescence or early 20s in men and 20s and early 30s in women.  The DSM-IV diagnostic criteria for schizophrenia includes:  at least 6 months of sufficiently deteriorated occupational, interpersonal and self-supportive functioning; two or more of the following positive symptoms: delusions, hallucinations, disorganized speech or behavior; or negative symptoms such as affective flattening, alogia or avolition during a 1 month period.  The symptoms can not be accounted for by the presence of a schizoaffective or major mood disorder, autism, or an organic condition.  Positive and negative symptoms vary in intensity over time.  Criminal behavior is not a characteristic of schizophrenia however, patients may commit violent acts due to their hallucinations, delusions, or impaired social skills.  The lifetime prevalence of suicide is 10 percent amongst schizophrenics.

    Multiple genetic and environmental factors are responsible for the symptoms seen in schizophrenia.  One factor is the dopamine theory in which increased dopaminergic neurotransmission causes psychosis.  By decreasing dopaminergic transmission via antipsychotic drugs, the distractibility seen in schizophrenia decreases and improves perceptual abilities.  The theory has several flaws.  First, symptoms are not fully alleviated by treatment.  Secondly, dopamine levels are within normal ranges before and after treatment.  Thirdly, dopamine and its role in the brain is more complex than acting as a simple switch for psychotic symptoms.  Inhibitory interneurons are also affected by a decrease in their number, in enzymes that synthesize the inhibitory neurotransmitter gamma-aminobutyric acid, in neuropeptides cholecystokinin and somatostatin, and in migration of neurons into the cortex from white matter.  There are also genetic findings such as greater concordance among monozygotic twins than dizygotic twins and the high incidence of schizophrenia among adopted children, whose biologic mothers have schizophrenia.  These findings point to a genetic component that accounts for 70 percent of the risk.  The environmental component accounts for the remaining 30 percent, that includes perinatal and childhood brain injury and psychosocial stressors.

    The pharmacologic approach to schizophrenia and its symptoms is centered on neurotransmitters that control the response of neurons to stimuli.  First generation antipsychotic agents such as haloperidol and chlorpromazine block dopamine D2 receptors.  Twenty percent of patients have complete remission of their symptoms, most patients have some response but with continuing symptoms.  Side effects include involuntary movement disorders arising from the extrapryamidal system.  Symptoms include dystonia, akathisia, bradykinesia and tremor.  Akathisia, a state of restlessness, is a major cause of noncompliance with the drug regimen.  It can be treated with propranolol.  Bradykinesia, slowed voluntary movements can be treated with benzotropine.  Tardive dyskinesia, a choreoathetotic movement disorder, develops in 30 percent of patients after several years of treatment.  Orofacial movements are common manifestations.  It slowly resolves after withdrawal of first generation drugs, although it may be irreversible.  When diagnosed early it is usually reversed with a change in medication.  Temperature dysregulation can lead to neuroleptic malignant syndrome, in which the patient’s temperature exceeds 104°F.  Dantrolene, bromocriptine, and rapid cooling can be used to treat the hyperthermia.  Prolonged QT interval is seen in several antipsychotics, in particular thioridazine. 

    Second generation antipsychotic agents block D2 dopamine receptors (like first generation drugs) however they are less tightly bound and the D2 dopamine receptor antagonism is not the sole therapeutic mechanism.  They include clozapine, risperidone, olanzapine, ziprasidone, quetiapine, ariprazole and amisulpride.  Their efficacy is equivalent or exceeds the first generation drugs particularly with respect to negative symptoms.  Side effects include weight gain, DM, hypercholesterolemia, hyperprolactinemia, and seizures.  Movement disorders, including tardive dyskinesia are decreased with the second generation drugs.  Clozapine was the first second generation drug to be used and it also blocks D1, D4 dopamine receptors and norepinephrine and serotonin receptors.  Agranulocytosis is a serious risk associated with clozapine and patients taking the drug must undergo frequent monitoring of leukocyte counts.  They are also at risk for myocarditis.  Agranulocytosis can lead to fevers, malaise and frequent infections in the schizophrenic patient.  For noncompliant patients there are depot injection preparations available.

    The primary mode of treatment of schizophrenia is pharmacologic.  Supportive psychosocial methods are useful in the long-term treatment of schizophrenia.  If the acutely psychotic schizophrenic is delirious, suicidal or homicidal and/or has no support, the patient needs to be hospitalized.
 
 

Add comment

Security code
Refresh

Popular Authors

  • Greg Henry
  • Rick Bukata
  • Mark Plaster
  • Kevin Klauer
  • Jesse Pines
  • David Newman
  • Rich Levitan
  • Ghazala Sharieff
  • Nicholas Genes
  • Jeannette Wolfe
  • William Sullivan
  • Michael Silverman

Subscribe to EPM